TRAVERSA SERGIO — SEC insider filings

SEC reporting owner CIK 1565832. 27 insider filings on record with FilingPulse; latest filed 2026-09-11.

Transaction summary — filings shown

Covers all 27 filings on record, filed 2020-08-19 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
RELMADA THERAPEUTICS, INC. (RLMD)Chief Executive Officer, Director2717 legs · 1,411,226 sh · $2,791,26424 legs · 79,767 sh · $2,285,20136

Insider filings — TRAVERSA SERGIO

FiledFormIssuerReported transactionsSource
2026-09-114RELMADA THERAPEUTICS, INC. (RLMD)Purchase (P): 100,000 @ $4.18 · Purchase (P): 100,000 @ $4.10EDGAR
2025-12-164RELMADA THERAPEUTICS, INC. (RLMD)Purchase (P): 27,500 @ $4.12 · Grant/award (A): 1,198,000 (derivative) @ $0EDGAR
2025-11-064RELMADA THERAPEUTICS, INC. (RLMD)Purchase (P): 272,500 @ $2.20EDGAR
2025-08-284RELMADA THERAPEUTICS, INC. (RLMD)Purchase (P): 80,545 @ $0.62 · Purchase (P): 129,455 @ $0.67 · Purchase (P): 55,976 @ $0.74EDGAR
2025-06-304RELMADA THERAPEUTICS, INC. (RLMD)Grant/award (A): 800,000 (derivative) @ $0EDGAR
2025-05-204RELMADA THERAPEUTICS, INC. (RLMD)Purchase (P): 172,314 @ $0.45 · Purchase (P): 30,000 @ $0.50 · Purchase (P): 147,686 @ $0.56EDGAR
2024-09-114RELMADA THERAPEUTICS, INC. (RLMD)Purchase (P): 55,579 @ $2.71 · Purchase (P): 33,014 @ $2.75 · Purchase (P): 51,407 @ $2.99EDGAR
2024-05-294RELMADA THERAPEUTICS, INC. (RLMD)Grant/award (A): 122,358 (derivative) @ $0 · Other (J): 122,358 (derivative) @ $0EDGAR
2024-01-314RELMADA THERAPEUTICS, INC. (RLMD)Purchase (P): 31,541 @ $3.71 · Purchase (P): 40,999 @ $3.90 · Purchase (P): 27,460 @ $4.00EDGAR
2023-12-194RELMADA THERAPEUTICS, INC. (RLMD)Grant/award (A): 183,881 (derivative) @ $0EDGAR
2023-05-304RELMADA THERAPEUTICS, INC. (RLMD)Grant/award (A): 527,211 (derivative) @ $0EDGAR
2022-12-204RELMADA THERAPEUTICS, INC. (RLMD)Grant/award (A): 323,517 (derivative) @ $0EDGAR
2022-12-204RELMADA THERAPEUTICS, INC. (RLMD)Other (J): 300,000 (derivative)EDGAR
2022-12-124RELMADA THERAPEUTICS, INC. (RLMD)Purchase (P): 55,250 @ $2.10EDGAR
2022-07-054RELMADA THERAPEUTICS, INC. (RLMD)Option exercise (M): 16,012 @ $16 · Sale (S): 5,314 @ $19.37 · Sale (S): 10,698 @ $19.01 · Option exercise (M): 13,755 @ $16 · Sale (S): 839 @ $18.48 · Sale (S): 8,848 @ $18.45 · +3 moreEDGAR
2022-05-264RELMADA THERAPEUTICS, INC. (RLMD)Grant/award (A): 651,821 (derivative) @ $0 · Grant/award (A): 300,000 (derivative) @ $0EDGAR
2021-12-214RELMADA THERAPEUTICS, INC. (RLMD)Grant/award (A): 492,173 (derivative) @ $0EDGAR
2021-03-114RELMADA THERAPEUTICS, INC. (RLMD)Option exercise (M): 10,000 @ $3.24 · Sale (S): 5,217 @ $35.42 · Sale (S): 1,800 @ $36.32 · Sale (S): 2,983 @ $35.09 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-02-264RELMADA THERAPEUTICS, INC. (RLMD)Option exercise (M): 10,000 @ $3.24 · Sale (S): 4,837 @ $33.69 · Sale (S): 4,860 @ $34.70 · Sale (S): 303 @ $35.55 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-02-164RELMADA THERAPEUTICS, INC. (RLMD)Option exercise (M): 1,446 @ $3.24 · Sale (S): 1,446 @ $35.43 · Option exercise (M): 1,446 (derivative) @ $0EDGAR
2021-02-104RELMADA THERAPEUTICS, INC. (RLMD)Option exercise (M): 11,206 @ $3.24 · Sale (S): 3,313 @ $35.03 · Sale (S): 5,963 @ $35.21 · Sale (S): 1,930 @ $35.28 · Option exercise (M): 11,206 (derivative) @ $0EDGAR
2021-02-044RELMADA THERAPEUTICS, INC. (RLMD)Option exercise (M): 3,278 @ $3.24 · Sale (S): 3,178 @ $35.08 · Sale (S): 100 @ $35 · Option exercise (M): 3,278 (derivative) @ $0EDGAR
2021-02-044RELMADA THERAPEUTICS, INC. (RLMD)Option exercise (M): 13,281 @ $3.24 · Option exercise (M): 13,281 (derivative) @ $0EDGAR
2021-01-294RELMADA THERAPEUTICS, INC. (RLMD)Option exercise (M): 10,000 @ $3.24 · Sale (S): 4,351 @ $31.77 · Sale (S): 5,549 @ $32.86 · Sale (S): 100 @ $33.43 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-01-264RELMADA THERAPEUTICS, INC. (RLMD)Option exercise (M): 4,070 @ $3.24 · Sale (S): 1,736 @ $35.44 · Sale (S): 434 @ $36.15 · Sale (S): 1,300 @ $35.29 · Sale (S): 600 @ $35.15 · Option exercise (M): 4,070 (derivative) @ $0EDGAR
2021-01-114RELMADA THERAPEUTICS, INC. (RLMD)Grant/award (A): 250,000 (derivative) @ $0 · Grant/award (A): 250,000 (derivative) @ $0EDGAR
2020-08-194RELMADA THERAPEUTICS, INC. (RLMD)Option exercise (M): 50,008 @ $3.24 · Tax withholding (F): 4,151 @ $39.03 · Option exercise (M): 50,008 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1565832 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs